Literature DB >> 31523918

Hypertension and hyperhomocysteinemia as risk factors for chronic kidney disease: A dangerous duo?

Alexandra Katsimardou1, Konstantinos Stavropoulos1, Konstantinos Imprialos1, Michael Doumas1, Vasilios G Athyros1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31523918      PMCID： PMC8030421          DOI： 10.1111/jch.13676

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  17 in total

1.  CKD Prevalence Varies across the European General Population.

Authors:  Katharina Brück; Vianda S Stel; Giovanni Gambaro; Stein Hallan; Henry Völzke; Johan Ärnlöv; Mika Kastarinen; Idris Guessous; José Vinhas; Bénédicte Stengel; Hermann Brenner; Jerzy Chudek; Solfrid Romundstad; Charles Tomson; Alfonso Otero Gonzalez; Aminu K Bello; Jean Ferrieres; Luigi Palmieri; Gemma Browne; Vincenzo Capuano; Wim Van Biesen; Carmine Zoccali; Ron Gansevoort; Gerjan Navis; Dietrich Rothenbacher; Pietro Manuel Ferraro; Dorothea Nitsch; Christoph Wanner; Kitty J Jager
Journal:  J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 10.121

2.  Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Authors:  Paul E Drawz; Arnold B Alper; Amanda H Anderson; Carolyn S Brecklin; Jeanne Charleston; Jing Chen; Rajat Deo; Michael J Fischer; Jiang He; Chi-Yuan Hsu; Yonghong Huan; Martin G Keane; John W Kusek; Gail K Makos; Edgar R Miller; Elsayed Z Soliman; Susan P Steigerwalt; Jonathan J Taliercio; Raymond R Townsend; Matthew R Weir; Jackson T Wright; Dawei Xie; Mahboob Rahman
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-18       Impact factor: 8.237

Review 3.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

4.  Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries.

Authors:  Clara K Chow; Koon K Teo; Sumathy Rangarajan; Shofiqul Islam; Rajeev Gupta; Alvaro Avezum; Ahmad Bahonar; Jephat Chifamba; Gilles Dagenais; Rafael Diaz; Khawar Kazmi; Fernando Lanas; Li Wei; Patricio Lopez-Jaramillo; Lu Fanghong; Noor Hassim Ismail; Thandi Puoane; Annika Rosengren; Andrzej Szuba; Ahmet Temizhan; Andy Wielgosz; Rita Yusuf; Afzalhussein Yusufali; Martin McKee; Lisheng Liu; Prem Mony; Salim Yusuf
Journal:  JAMA       Date:  2013-09-04       Impact factor: 56.272

Review 5.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Jicheng Lv; Parya Ehteshami; Mark J Sarnak; Hocine Tighiouart; Min Jun; Toshiharu Ninomiya; Celine Foote; Anthony Rodgers; Hong Zhang; Haiyan Wang; Giovanni F M Strippoli; Vlado Perkovic
Journal:  CMAJ       Date:  2013-06-24       Impact factor: 8.262

6.  Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Authors:  Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey
Journal:  Ann Intern Med       Date:  2003-08-19       Impact factor: 25.391

Review 7.  The double challenge of resistant hypertension and chronic kidney disease.

Authors:  Patrick Rossignol; Ziad A Massy; Michel Azizi; George Bakris; Eberhard Ritz; Adrian Covic; David Goldsmith; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Alberto Ortiz; Raymond Vanholder; Andrzej Wiecek; Carmine Zoccali; Gérard Michel London; Bénédicte Stengel; Denis Fouque
Journal:  Lancet       Date:  2015-10-17       Impact factor: 79.321

8.  Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

Authors:  Rex L Jamison; Pamela Hartigan; James S Kaufman; David S Goldfarb; Stuart R Warren; Peter D Guarino; J Michael Gaziano
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

Review 9.  A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.

Authors:  Katherine T Mills; Yu Xu; Weidong Zhang; Joshua D Bundy; Chung-Shiuan Chen; Tanika N Kelly; Jing Chen; Jiang He
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

Review 10.  Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?

Authors:  Giuseppe Cianciolo; Antonio De Pascalis; Luca Di Lullo; Claudio Ronco; Chiara Zannini; Gaetano La Manna
Journal:  Cardiorenal Med       Date:  2017-06-21       Impact factor: 2.041
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.